-
EP4337323
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4337323
| EP4337323 - BICYCLIC HETEROCYCLIC COMPOUNDS FOR PROPHYLAXIS AND TREATMENT OF VIRAL INFECTIONS [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 16.02.2024 Database last updated on 10.03.2026 | |
| Former | The international publication has been made Status updated on 29.11.2022 | Most recent event Tooltip | 23.01.2026 | New entry: Application deemed to be withdrawn: despatch of communication + time limit | Applicant(s) | For all designated states BM Pharma Consulting Pty. Ltd C/- 3/6 Tarawa Street Parrearra QLD, 4575 / AU | [2024/12] | Inventor(s) | 01 /
MOONEY, Brett Antony Ommaney, QLD, 4074 / AU | 02 /
NARASIMHAN, Rangachari Sunnyvale, CA 94087 / US | [2024/12] | Representative(s) | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | [2024/12] | Application number, filing date | 22806931.6 | 04.05.2022 | [2024/12] | WO2022IB54130 | Priority number, date | US202163188779P | 14.05.2021 Original published format: US 202163188779 P | [2024/12] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022238816 | Date: | 17.11.2022 | Language: | EN | [2022/46] | Type: | A1 Application with search report | No.: | EP4337323 | Date: | 20.03.2024 | Language: | EN | The application published by WIPO in one of the EPO official languages on 17.11.2022 takes the place of the publication of the European patent application. | [2024/12] | Search report(s) | International search report - published on: | AU | 17.11.2022 | (Supplementary) European search report - dispatched on: | EP | 12.06.2025 | Classification | IPC: | A61P31/12, C07H19/02, C07D487/04, C07D491/04 | [2024/12] | CPC: |
A61P31/12 (EP,AU);
C07H19/02 (EP,AU);
C07H19/056 (US);
A61K31/706 (US);
C07D487/04 (EP,AU);
C07D491/04 (AU);
Y02A50/30 (EP)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2024/12] | Title | German: | BICYCLISCHE HETEROCYCLISCHE VERBINDUNGEN ZUR PROPHYLAXE UND BEHANDLUNG VON VIRUSINFEKTIONEN | [2024/12] | English: | BICYCLIC HETEROCYCLIC COMPOUNDS FOR PROPHYLAXIS AND TREATMENT OF VIRAL INFECTIONS | [2024/12] | French: | COMPOSÉS HÉTÉROCYCLIQUES BICYCLIQUES POUR LA PROPHYLAXIE ET LE TRAITEMENT D'INFECTIONS VIRALES | [2024/12] | Entry into regional phase | 20.11.2023 | National basic fee paid | 20.11.2023 | Search fee paid | 20.11.2023 | Designation fee(s) paid | 20.11.2023 | Examination fee paid | Examination procedure | 20.11.2023 | Examination requested [2024/12] | 20.06.2024 | Amendment by applicant (claims and/or description) | 21.01.2026 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | Fees paid | Renewal fee | 26.04.2024 | Renewal fee patent year 03 | 28.04.2025 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | No further relevant documents disclosed | International search | [X] CN111995649 (HANHAI XINTUO HANGZHOU BIOLOGICAL MEDICINE CO LTD et al.) [X] 1-12, 35-44 * Abstract; compounds on pages 11-18 & pages 30-37; compounds S58 & S61 on page 16; Tables 1 to 5, pages 86-97; & claims 12-14, pages 18-19; claim 11, page 18 * | [X] US3798210 (PFLEIDERER W et al.) [X] 1-3, 5-6, 35-44 * Examples 6 & 9-22; Example 23 in column 31; lines 42-45, column 5; lines 18-26, column 7 * | [X] WO2014160200 (DANA FARBER CANCER INST INC et al.) [X] 1-6, 14-16 * Abstract; Compounds on pages 7-9; pages 3-6 & 100-106; claims 28-38, pages 153-154; pages 88-100; claims 25-26, page 153 * | [X] WO2007144686 (IDENIX CAYMAN LTD et al.) [X] 1-19, 35-44 * Abstract; see item VIII on biological data on pages 132-136; Figure 1, 1/3-3/3; lines 1-13, page 28; see also see item IV "Alternation and Combination Therapy", pages, 87-97; & item V "Pharmaceutical Compositions", pages 97-100; formulae xxii & x on pages 15 & 38 * | [X] WO2011035231 (GILEAD SCIENCES INC et al.) [X] 1-6, 14-19, 35-44 * Abstract; pages 4-7 & 146-150; compound 21, page 137; & compounds online 6, page 27; line 10, page 30; & lines 9-10 page 31; "Combination Therapy", pages 96-105; & "Pharmaceutical Compositions", pages 88-96; lines 22 & 23-27, page 6 * | [X] CN101289455 (GUANGYI JIN et al.) [X] 1-7, 9, 12-13, 26, 35-44 * Compound 36, pages 7 & 11; claim 6-7, page 2 * | [X] WO2018098207 (CV6 THERAPEUTICS NI LTD et al.) [X] 1-6, 20, 22-26, 35-44 * Abstract; Compound 1305, Table 2, page 124; & claim 28, page 334; claim 29, page 335; & pages 190-192 * | [X] KIM SUNGJOONG, WON WOOYEON, KANG YONGHAN: "Ring Opening Reaction of Pyrazolo[3,4- c ]Maleimide Nucleosides", NUCLEOSIDES AND NUCLEOTIDES, TAYLOR & FRANCIS, US, vol. 16, no. 10-11, 1 October 1997 (1997-10-01), US , pages 2025 - 2033, XP093007970, ISSN: 0732-8311, DOI: 10.1080/07328319708002553 [X] 1-6, 20-22 * Intermediate compound 11 in Scheme 2 on page 2027 * DOI: http://dx.doi.org/10.1080/07328319708002553 | [X] CHANG, W. ET AL.: "Discovery of PSI-353661, a Novel Purine Nucleotide Prodrug for the Treatment of HCV Infection", ACS MEDICINAL CHEMISTRY LETTERS, vol. 2, no. 2, 2011, pages 130 - 135, XP055531154, DOI: 10.1021/ml100209f [X] 1-6, 14-17, 35-44 * Title; Abstract; Tables 1 & 2, pages 131-132; Compound PSI-353661 & compounds 8-10 & 19-27, Table 2; treatment of HCV infections, page 134 * DOI: http://dx.doi.org/10.1021/ml100209f |